CRVS, CTMX and NRXP Are Among Premarket Gainers
Seeking AlphaMay 6 08:39 ET
Recent Uptick Might Appease OptiNose, Inc. (NASDAQ:OPTN) Institutional Owners After Losing 50% Over the Past Year
Yahoo FinanceMay 5 08:39 ET
Analysts' Top Healthcare Picks: Longeveron (LGVN), Optinose (OPTN)
TipRanksApr 29 06:20 ET
Express News | HC Wainwright & Co. Reiterates Buy on OptiNose, Maintains $5 Price Target
BenzingaApr 29 06:19 ET
OptiNose Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/29/2024 472.48% HC Wainwright & Co. → $5 Reiterates Buy → Buy 03/18/2024 357.98% Lake Street $3 → $4 Ma
BenzingaApr 29 06:17 ET
Why Caterpillar Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Caterpillar Inc. (NYSE:CAT) fell sharply during Thursday's session after the company reported better-than-expected first-quarter EPS but missed revenue estimates.Caterpillar reported a first
BenzingaApr 25 13:57 ET
Market-Moving News for April 25th
ULBI: 26% | Ultralife shares are trading higher after the company reported better-than-expected Q1 financial results.CDTX: 41% | Cidara Therapeutics shares are trading higher after the company announc
BenzingaApr 25 08:31 ET
Optinose OPTN Product Revenue; Biophytis BPTS NASDAQ Delist
BioPharmCatalystApr 25 08:26 ET
Express News | OptiNose Inc - Expects to Produce Positive Income From Operations (Gaap) for Full Year 2025
ReutersApr 25 07:04 ET
Express News | OptiNose Outlook FY Revenue USD 300 Million
ReutersApr 25 07:00 ET
Express News | OptiNose Provides Corporate Update on Xhance Launch and Outlook and Announces Preliminary First Quarter 2024 Xhance Net Revenue of $14.9 Million
ReutersApr 25 07:00 ET
Express News | OptiNose Q1 Revenue USD 14.9 Million Vs. Ibes Estimate USD 12.9 Million
ReutersApr 25 07:00 ET
12 Health Care Stocks Moving In Monday's After-Market Session
GainersNuwellis (NASDAQ:NUWE) stock rose 46.8% to $0.48 during Monday's after-market session. The company's market cap stands at $3.2 million. Sensei Biotherapeutics (NASDAQ:SNSE) stock rose 7.42% to
BenzingaApr 22 16:31 ET
Positive Sentiment Still Eludes OptiNose, Inc. (NASDAQ:OPTN) Following 35% Share Price Slump
OptiNose, Inc. (NASDAQ:OPTN) shareholders won't be pleased to see that the share price has had a very rough month, dropping 35% and undoing the prior period's positive performance.
Simply Wall StApr 14 09:06 ET
OptiNose (NASDAQ:OPTN) Shareholders Have Endured a 87% Loss From Investing in the Stock Five Years Ago
Yahoo FinanceApr 6 10:07 ET
Optinose to Present at the Needham Virtual Healthcare Conference
YARDLEY, Pa., April 04, 2024 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced t
OptiNoseApr 4 00:00 ET
Lake Street Remains a Buy on Optinose (OPTN)
TipRanksMar 26 08:45 ET
Optinose Is Maintained at Buy by Lake Street
Optinose Is Maintained at Buy by Lake Street
Dow JonesMar 18 09:44 ET
Express News | Lake Street Maintains Buy on OptiNose, Raises Price Target to $4
Moomoo 24/7Mar 18 09:34 ET
Sector Update: Health Care Stocks Steady Premarket Monday
Health care stocks were steady premarket Monday as the iShares Biotechnology ETF (IBB) was unchanged and the Health Care Select Sector SPDR Fund (XLV) was slightly higher recently. Fennec Pharmaceutic
MT NewswiresMar 18 09:16 ET
No Data
No Data